awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36671812-1DE8555C-A130-41C2-8D84-CFA7EC5812C4
Q36671812-1DE8555C-A130-41C2-8D84-CFA7EC5812C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36671812-1DE8555C-A130-41C2-8D84-CFA7EC5812C4
Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
P2860
Q36671812-1DE8555C-A130-41C2-8D84-CFA7EC5812C4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36671812-1DE8555C-A130-41C2-8D84-CFA7EC5812C4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0a0dcd4b238a5a2ecd1048c9f59c1766da75edf
P2860
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the Nati